th2 Modulation CRSwNP
Phase 4
Not yet recruiting
- Conditions
- Chronic Rhinosinusitis With Nasal Polyps
- Interventions
- First Posted Date
- 2023-10-30
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- St. Paul's Sinus Centre
- Target Recruit Count
- 40
- Registration Number
- NCT06107101
- Locations
- 🇨🇦
St. Paul's Sinus Centre, Vancouver, British Columbia, Canada
Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment
Phase 4
Recruiting
- Conditions
- Chronic Rhinosinusitis With Nasal PolypsAsthmaChronic Rhinosinusitis Without Nasal Polyps
- Interventions
- Other: PlaceboBiological: Mepolizumab
- First Posted Date
- 2022-12-08
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- St. Paul's Sinus Centre
- Target Recruit Count
- 90
- Registration Number
- NCT05642806
- Locations
- 🇨🇦
St. Pual's Sinus Centre, Vancouver, British Columbia, Canada
Allergic Rhinitis Combination Pharmacotherapy Efficacy Study
Phase 4
Withdrawn
- Conditions
- Allergic Rhinitis
- Interventions
- First Posted Date
- 2020-10-23
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- St. Paul's Sinus Centre
- Registration Number
- NCT04601324
Utility of Indocyanine Green Fluorescence in Endoscopic Sinonasal and Skull Base Surgery
Not Applicable
Not yet recruiting
- Conditions
- Chronic SinusitisPosterior EpistaxisSkull Base NeoplasmsTumor of Nasal Sinus
- Interventions
- Procedure: Skull Base Surgery (Assessment of Nasoseptal Flap)Procedure: Sinonasal Benign or Malignant Tumor ResectionProcedure: Posterior Epistaxis Management (SPA Ligation)Procedure: Endoscopic Sinus Surgery
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2022-11-14
- Lead Sponsor
- St. Paul's Sinus Centre
- Target Recruit Count
- 40
- Registration Number
- NCT04374448
© Copyright 2025. All Rights Reserved by MedPath